US Patent 11040039 Treatment of inflammatory disorders
Patent 11040039 was granted and assigned to Aldeyra Therapeutics on June, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 10, 2018
Date of Patent
June 22, 2021
Patent Applicant
Patent Application Number
16157069
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11040039 Treatment of inflammatory disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
